Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.43    -0.005 (-0.21%)
Bid:
2.43
Ask:
2.44
Spread: 0.01 (0.412%)
Market Cap: $8.02b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Resolutions Ordinary General Assembly March 2026

16 Mar 2026 07:00

RNS Number : 6754W
Commercial Intnl Bank (Egypt) SAE
15 March 2026
 

 

http://www.rns-pdf.londonstockexchange.com/rns/6754W_1-2026-3-15.pdf1/4

 

Ordinary General Assembly

15 March 2026

 

Resolutions Summary

 

 

Item (1)

 

Board of Directors Report for the Fiscal Year 2025

 

The General Assembly ratified the presented Board of Directors' Report for the Fiscal Year ending 31/12/2025.

 

Item (2)

 

Governance Report and External Auditors' Report

for the Fiscal Year 2025

 

The General Assembly ratified the presented Governance Report issued by the Board of Directors for the Fiscal Year ending 31/12/2025 and the associated External Auditors' Reports.

 

Item (3)

 

External Auditors' Reports for the Fiscal Year 2025

 

The General Assembly ratified the External Auditors' Reports for the Separate and Consolidated Financial Statements for the Fiscal Year ending 31/12/2025.

 

Item (4)

Separate and Consolidated Financial Statements

For the Fiscal Year 2025

 

The General Assembly ratified the separate and consolidated Financial Statements for the year ending 31/12/2025.

 

 

Item (5)

 

Recommended Appropriation Account

For the Fiscal Year 2025

 

The General Assembly approved the proposed Appropriation Account for 2025 profit share distribution and delegated the Board of Directors to approve the guidelines for the profit share distribution to the staff for the year 2025.

 

The General Assembly also approved cash dividends payout of EGP 6 per share to be paid on Thursday, April 9, 2026.

 

2/4

 

Item (6)

 

Authorization to the Board of Directors

To pay profit share to former employees resigned in 2024

 

The General Assembly approved to authorize the Board of Directors to pay the amount of EGP 27,542,117 as profit share to former employees who resigned in 2024. The amount is to be deducted from Retained Earnings, in accordance with the amended 2024 staff profit share distribution guidelines in alignment with CBE regulations.

 

Item (7)

 

Increasing the Issued and Paid-in Capital

to Fulfill the ESOP "Year 17"

 

The General Assembly approved increase the issued and paid in capital by (27,203,000) common shares at nominal value of EGP 10 per share, an increase of EGP 272,030,000, to effect the vesting terms for "Year 17" of the "ESOP", approved by the Financial Regulatory Authority.

 

The General Assembly also approved amending Articles "6" and "7" of the Bank's Bylaws to reflect the mentioned increase, subject to the approval of the Central Bank of Egypt.

 

The General Assembly delegated the CEO & Board Member to fulfill the capital increases procedural requirements after obtaining the required approvals, with the right to delegate others in doing so, without prejudice to the Listing and Delisting Rules and its Executive Regulations issued by the Financial Regulatory Authority and effected by the Egyptian Stock Exchange, and also delegated Mr. Mahmoud Abbas Mohamed Ahmed, Chief Legal Officer, to sign the amendment agreements of the Bank's Statutes at the respective Notary Office.

 

Item (8)

 

Approve the changes to the Board of Directors' composition

since the previous General Assembly of September 25, 2025

 

The General Assembly noted and approved the changes to the composition of the Board of Directors that took place since the last General Assembly held September 25, 2025.

 

 

3/4

 

Item (9)

 

Discharging the Board of Directors for Fiscal Year 2025

 

The General Assembly approved discharging the Chair and Members of the Board from all liabilities with regard to the Bank's activities during the Fiscal Year 2025.

 

 

Item (10)

 

Elect the Members of the Board for the upcoming Board Term

(March 2026 - March 2029)

 

In view of the listed nominees, approved by the Central Bank of Egypt, presented to the General Assembly for election to serve the new Board Term (March 2026 - March 2029), the General Assembly approved the new Board of Directors' composition to be as follows:

 

· Ms. Neveen Aly Fayek Sabbour Non-Executive Chair (Independent)

· Mr. Amin Hisham Mohamed Amin Ezz Al-Arab Chief Executive Officer

· Mr. Fadhel Abdul Baqy Abulhasan Alqaed AlAli Non-Executive Director

(representing Alpha Oryx Ltd.)

· Mr. Aziz Moolji Non-Executive Director

(representing Alpha Oryx Ltd.)

· Ms. Hoda Ahmed Mohamed Mansour ElAskalany Non-Executive Director (Independent)

· Mr. Jawaid Mirza Non-Executive Director

· Mr. Burkhard Eckes Non-Executive Director (Independent)

· Mr. Georgios Anagnostopoulos Non-Executive Director (Independent)

· Ms. Tanvi Davda Non-Executive Director (Independent)

· Mr. Amr El-Ganainy Deputy CEO

· Mr. Islam Zekry Group Chief Finance & Operations

 

 

 

 

 

 

 

 

4/4

 

 

Item (11)

 

2026 Proposed Sitting Fees for the Directors of the Board

 

The General Assembly approved the annual net sitting fees of EGP 360,000 to be paid to each Non-Executive Director for Fiscal Year 2026.

 

 

 

Item (12)

 

Appointment of the Bank's External Auditors

For the Fiscal Year 2026 and Approving their Fees

 

The General Assembly approved the appointment of "Mr. Abdelhadi Mohamed Ali Ibrahim, Partner, (KPMG Hazem Hassan - Public Accountants & Consultants)" and "Mr. Hossam El-Din Mohamed Abdallah Hilal, Partner - Baker Tilly Mohamed Hilal and Wahid Abdel Ghaffar  Legal Auditors & Consultants" as the Bank's Auditors for the Fiscal Year 2026.

 

The General Assembly approved their total audit fees of EGP 14.7mn (excluding VAT) for auditing the Bank's annual and quarterly standalone and consolidated financial statements and issuing related reports.

 

Item (13)

 

Authorization to the Board of Directors

to Approve Donations in 2026

 

The General Assembly approved authorizing the Board of Directors to donate above EGP 1000 per recipient during the year 2026 in conformity with Article "101" of the Corporate Law No. 159 of the year 1981. The General Assembly also approved the amounts donated during 2025.

 

 

Item (14)

 

Authorization to Non-Executive Directors

To Assume Executive Roles in Other Companies

 

The General Assembly approved authorizing the Non-Executive Directors to assume full time jobs (technical or administrative) in other shareholding companies in conformity with Article "95" of the Corporate Law No. 159 of the year 1981.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGZZGMFFKMGVZM
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.